Related Experiment Video

Updated: Jun 6, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens

Petr G Lokhov1, Elena E Balashova

  • 11. ZAO BioBohemia, Moscow, Russia.

Journal of Cancer
|December 15, 2010
PubMed

Insights

Cancer cell vaccines show promise but lack long-term benefits due to non-specific antigens. Enhancing vaccines with cancer-specific antigens could improve therapeutic outcomes for cancer immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Cancer cell-based vaccines are an emerging anti-cancer therapy.
  • Current vaccines show limited long-term therapeutic efficacy.
  • Ubiquitous intracellular molecules in vaccines can dilute the immune response.

Purpose of the Study:

  • To review the cell surface of cancer cells for vaccine development.
  • To discuss strategies for improving antigen composition in cancer vaccines.
  • To enhance the effectiveness of cancer cell-based immunotherapies.

Main Methods:

  • Review of existing literature on cancer cell-based vaccines.
  • Analysis of cancer cell surface antigens and intracellular components.
  • Discussion of strategies for antigen enrichment in vaccine development.

Main Results:

  • Cancer cells contain both target antigens and non-specific intracellular molecules.
  • Non-specific molecules can lead to insufficient immune responses against cancer cells.
  • Enriching vaccines with cancer-specific antigens is crucial for efficacy.

Conclusions:

  • Improving the antigen profile of cancer vaccines is essential for therapeutic success.
  • Focusing on cancer-specific antigens can overcome limitations of current cancer cell-based vaccines.
  • Further research into antigen enrichment strategies is warranted for effective cancer immunotherapy.
Keywords:
antiangiogenic cancer vaccinecell surface antigenscellular cancer vaccine

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...